Roka Bioscience
ROKA

From December 31, 2016 to September 30, 2017 Issuance of restricted shares to employees, net of shares forfeited or withheld for taxes

from December 31, 2016 to February 1,2017 Issuance of restricted shares to employees, net of shares withheld for taxes

From December 31, 2015 to December 31, 2016 Conversion of convertible preferred stock into Common Stock Issuance of preferred stock Issuance of restricted shares to employees, net of shares withheld for taxes On October 11, 2016, Roka Bioscience, Inc. (ROKA), today announced that it is effecting a 1-for-10 reverse stock split of its common stock. Beginning with the opening of trading on October 12, 2016, the Company’s common stock will trade on a split-adjusted basis on the NASDAQ and will trade under a new CUSIP (775431208).

From December 31, 2015 to October 12, 2016 Issuance of Preferred Stock, net of issuance costs Issuance of restricted shares to employees, net of shares withheld for taxes On October 11, 2016, Roka Bioscience, Inc. (ROKA), today announced that it is effecting a 1-for-10 reverse stock split of its common stock. Beginning with the opening of trading on October 12, 2016, the Company’s common stock will trade on a split-adjusted basis on the NASDAQ and will trade under a new CUSIP (775431208).

From December 31, 2015 to September 30, 2016 Issuance of Preferred Stock, net of issuance costs Issuance of restricted shares to employees, net of shares withheld for taxes

from December 31, 2015 to March 31, 2016 Issuance of restricted shares to employees, net of shares withheld for taxes

from December 31, 2014 to December 31, 2015 Issuance of restricted shares to employees, net of taxes withheld Forfeiture of unvested restricted shares Exercise of options for Common Stock

from December 31, 2014 to September 14, 2015 Exercise of options for Common Stock Issuance of restricted shares to employees, net of shares withheld for taxes

From December 31, 2014 to June 30, 2015 Issuance of restricted shares to employees, net of shares withheld for taxes Exercise of options for Common Stock

from December 31, 2014 to March 31, 2015 Issuance of restricted shares to employees, net of shares withheld for taxes Exercise of options for Common Stock

from December 31, 2013 to December 31, 2014 Issuance of common stock from initial public offering, net of underwriters’ discounts and issuance costs Conversion of convertible preferred stock into Common Stock Issuance of common stock upon exercise of option in amended license agreement Issuance of restricted shares to employees, net of shares withheld for taxes Exercise of options for Common Stock a 1-for-11.04 reverse split of our common stock effected on July 3, 2014

from December 31, 2013 to September 30, 2014 Conversion of convertible preferred stock into Common Stock Issuance of common stock from initial public offering, net of underwriters’ discounts and issuance costs Issuance of common stock for royalty reduction Exercise of options for Common Stock a 1-for-11.04 reverse split of our common stock effected on July 3, 2014

A 1-for-11.04 reverse split of the company's common stock effected on July 3, 2014 the conversion of all of the company's outstanding shares of preferred stock into an aggregate of 10,494,557 shares of common stock upon the completion of this offering the elimination of the company's Series A common stock and Series B common stock and the creation of one series of common stock, which will occur upon completion of this offering the conversion of warrants exercisable for 2,989,804 shares of preferred stock into warrants exercisable for an aggregate of 270,813 shares of common stock the issuance of 865,063 shares of the company's common stock to Gen-Probe within ten days following the closing of this offering pursuant to the exercise of the royalty reduction option contained in the amendment to the company's license agreement with Gen-Probe

a 1-for-11.04 reverse split of our common stock effected on July 3, 2014

from December 31, 2013 to June 30, 2014 Exercise of options for Common Stock

from December 31,2012 to December 31,2013 Issuance of Series E convertible preferred stock for cash at $1.275 per share Conversion of convertible preferred stock into Common Stock Issuance of restricted shares to employees Exercise of options for Common Stock Exercise of warrants for Series A Preferred Stock